American preclinical contract research company at Paramus in New Jersey with laboratories in New York state, founded in 1999. Tests candidate drugs for central nervous system conditions in animal models, using its SmartCube automated behavioural platform and machine learning to read drug effects, offers models of schizophrenia, depression, autism, Huntington's and Alzheimer's disease and also develops its own compounds with partners.
Aucun commentaire disponible.
Laissez votre note & commentaire